GlassScriptPhysician profile
Henry B Wilson
NPI 1558496117
$24,085.71
in general payments reported to CMS, 2019-2025
22 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,993 · 2021: $4,021 · 2022: $5,188 · 2023: $467 · 2024: $735 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $20,272.99 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,537.16 | 2020-2025 | |
| Allergan, INC. | $492.10 | 2019 | |
| Mentor Worldwide LLC | $368.30 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $287.24 | 2022-2025 | |
| Motiva USA, LLC | $194.16 | 2025 | |
| Abbvie INC. | $189.35 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Janssen Biotech, INC. | $124.23 | 2023-2024 | Tremfya |
| Sun Pharmaceutical Industries INC. | $92.07 | 2023-2024 | Blu-U, Odomzo |
| Tela Bio, INC. | $83.35 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Lilly USA, LLC | $62.89 | 2024-2025 | Ebglyss, Taltz, Zepbound |
| Genzyme Corporation | $61.36 | 2024 | |
| Ucb, INC. | $52.87 | 2024 | Bimzelx |
| Tempus Ai, INC | $47.98 | 2024 | |
| Organogenesis INC. | $39.12 | 2020-2025 | Puraply Wound Matrix |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $33.55 | 2022 | |
| Ethicon US, LLC | $27.90 | 2021 | |
| Integra Lifesciences Corporation | $26.50 | 2023 | Durasorb Monofilament Mesh |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.20 | 2024 | Cabtreo |
| Biotissue Holdings INC. | $22.95 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.72 | 2024 | Spevigo |
| Leo Pharma INC. | $22.72 | 2024 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.